These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 27052176)
21. p53 regulates the minimal promoter of the human topoisomerase IIalpha gene. Sandri MI; Isaacs RJ; Ongkeko WM; Harris AL; Hickson ID; Broggini M; Vikhanskaya F Nucleic Acids Res; 1996 Nov; 24(22):4464-70. PubMed ID: 8948636 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of topoisomerase IIα: novel function of wedelolactone. Benes P; Knopfova L; Trcka F; Nemajerova A; Pinheiro D; Soucek K; Fojta M; Smarda J Cancer Lett; 2011 Apr; 303(1):29-38. PubMed ID: 21315506 [TBL] [Abstract][Full Text] [Related]
23. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas. Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297 [TBL] [Abstract][Full Text] [Related]
24. Smurf2-Mediated Stabilization of DNA Topoisomerase IIα Controls Genomic Integrity. Emanuelli A; Borroni AP; Apel-Sarid L; Shah PA; Ayyathan DM; Koganti P; Levy-Cohen G; Blank M Cancer Res; 2017 Aug; 77(16):4217-4227. PubMed ID: 28611047 [TBL] [Abstract][Full Text] [Related]
25. Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a-/- mutants. Sapetto-Rebow B; McLoughlin SC; O'Shea LC; O'Leary O; Willer JR; Alvarez Y; Collery R; O'Sullivan J; Van Eeden F; Hensey C; Kennedy BN BMC Dev Biol; 2011 Nov; 11():71. PubMed ID: 22111588 [TBL] [Abstract][Full Text] [Related]
26. Myosin VI is differentially regulated by DNA damage in p53- and cell type-dependent manners. Cho SJ; Chen X J Biol Chem; 2010 Aug; 285(35):27159-27166. PubMed ID: 20576604 [TBL] [Abstract][Full Text] [Related]
27. Human topoisomerase IIalpha rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication forks. McClendon AK; Rodriguez AC; Osheroff N J Biol Chem; 2005 Nov; 280(47):39337-45. PubMed ID: 16188892 [TBL] [Abstract][Full Text] [Related]
28. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123 [TBL] [Abstract][Full Text] [Related]
29. p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POLθ pathways. Roy S; Tomaszowski KH; Luzwick JW; Park S; Li J; Murphy M; Schlacher K Elife; 2018 Jan; 7():. PubMed ID: 29334356 [TBL] [Abstract][Full Text] [Related]
30. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain. Qin Y; Meng L; Hu C; Duan W; Zuo Z; Lin L; Zhang X; Ding J Mol Cancer Ther; 2007 Sep; 6(9):2429-40. PubMed ID: 17876042 [TBL] [Abstract][Full Text] [Related]
31. Mre11 Is Essential for the Removal of Lethal Topoisomerase 2 Covalent Cleavage Complexes. Hoa NN; Shimizu T; Zhou ZW; Wang ZQ; Deshpande RA; Paull TT; Akter S; Tsuda M; Furuta R; Tsutsui K; Takeda S; Sasanuma H Mol Cell; 2016 Nov; 64(3):580-592. PubMed ID: 27814490 [TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation. Zhao H; Traganos F; Darzynkiewicz Z Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor. Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802 [TBL] [Abstract][Full Text] [Related]
34. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells. Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786 [TBL] [Abstract][Full Text] [Related]
35. Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription. Tuduri S; Crabbé L; Conti C; Tourrière H; Holtgreve-Grez H; Jauch A; Pantesco V; De Vos J; Thomas A; Theillet C; Pommier Y; Tazi J; Coquelle A; Pasero P Nat Cell Biol; 2009 Nov; 11(11):1315-24. PubMed ID: 19838172 [TBL] [Abstract][Full Text] [Related]
36. Oxocrebanine: A Novel Dual Topoisomerase inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest. Yu L; Han S; Lang L; Song H; Zhang C; Dong L; Jia S; Zhang Y; Xiao D; Liu J; Xu Y; Zhang X Phytomedicine; 2021 Apr; 84():153504. PubMed ID: 33611211 [TBL] [Abstract][Full Text] [Related]
37. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation. Shapiro AB; Austin CA Anal Biochem; 2014 Mar; 448():23-9. PubMed ID: 24309019 [TBL] [Abstract][Full Text] [Related]
38. Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26. Catapano CV; Carbone GM; Pisani F; Qiu J; Fernandes DJ Biochemistry; 1997 May; 36(19):5739-48. PubMed ID: 9153414 [TBL] [Abstract][Full Text] [Related]
39. Unprecedented citrinin trimer tricitinol B functions as a novel topoisomerase IIα inhibitor. Du L; Liu HC; Fu W; Li DH; Pan QM; Zhu TJ; Geng MY; Gu QQ J Med Chem; 2011 Aug; 54(16):5796-810. PubMed ID: 21761866 [TBL] [Abstract][Full Text] [Related]
40. Regulation of DNA topoisomerase IIalpha stability by the ECV ubiquitin ligase complex. Yun J; Kim YI; Tomida A; Choi CH Biochem Biophys Res Commun; 2009 Nov; 389(1):5-9. PubMed ID: 19695223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]